Bit Capital Gmb H Ventyx Biosciences, Inc. Transaction History

Bit Capital Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Feb 12, 2025	SELL	$1.85 - $3.2 $563,806 - $975,232	-304,760 Closed	0 $0
Q2 2024 Feb 12, 2025	BUY	$2.31 - $5.59 $286,560 - $693,450	124,052 Added 68.65%	304,760 $704 Million
Q1 2024 Feb 12, 2025	BUY	$1.9 - $10.13 $343,345 - $1.83 Million	180,708 New	180,708 $994 Million
Q4 2023 Feb 12, 2025	SELL	$2.08 - $31.18 $4,095 - $61,393	-1,969 Closed	0 $0
Q3 2023 Feb 12, 2025	BUY	$29.8 - $40.3 $58,676 - $79,350	1,969 New	1,969 $68.4 Million

130

53.3M

47.3K

83K

Ticker VTYX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,527,200
Market Cap $91.6M
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

Stay updated on Bit Capital Gmb H with notifications on news.